Home / Expertise / Intellectual Property
padlock hanging from turquoise painted wooden doors

Intellectual Property

Slovenia

The success of a company springs from its ideas. By obtaining, defending and licencing various property rights ranging from trademarks to designs, patents, protection certificates and utility models, this potential is transformed into financially measurable company values. A cohesive IP strategy, including both commercialisation and enforcement, will ensure you get maximum value from your portfolio.

With 150 IP-lawyers in 39 countries, we understand your business needs. CMS has worked with some of the best-known brands and we specialize in representing companies from the lifesciences, pharmaceutical, medical products, media, telecommunications, clothing, computer and consumer goods industries. We advise and represent clients during trademark registrations and similarity examinations, handle their trademark portfolios and potential breaches of their trademark, design, patent and protection certificate rights, and prosecute product piracy for our clients at customs authorities and courts across Europe. Our expertise extends to parallel and grey imports, sales rights and associated legal fields such as pharmaceutical products, media, telecommunications and broadcast law.

The right brands will win the hearts and minds of your customers. The right patents will prevent others exploiting your ideas or provide a substantial barrier to market access. Copyright, know-how and designs also play a vital role. In the event of a breach of property rights, we support our clients in asserting their rights before courts and criminal courts. Our range of services includes warnings, injunctions, lawsuits and border confiscations as well as the increasingly important international assertion of intellectual property rights.

Read more Read less

Feed

Show only
01/01/2018
Pro­tect­ing ideas, se­cur­ing profit
The suc­cess of a com­pany springs from its ideas. By ob­tain­ing, de­fend­ing and li­cen­cing vari­ous prop­erty rights ran­ging from trade­marks to designs, pat­ents, pro­tec­tion cer­ti­fic­ates and util­ity mod­els...
11 November 2020
CMS Ex­pert Guide to trans­fer­ring IP rights
In re­cent years, IP rights have be­come an in­creas­ingly im­port­ant as­set not only for R&D and tech­no­logy based com­pan­ies but also for con­sumer product man­u­fac­tur­ers and life sci­ences com­pan­ies, for ex­ample...
Comparable
15 December 2020
Five years after Hua­wei ZTE FRAND li­cens­ing ob­lig­a­tions again be­fore the...
On 26 Novem­ber 2020, the Düs­sel­dorf Re­gion­al Court an­nounced that it would sus­pend a pat­ent in­fringe­ment pro­ceed­ing and refer key ques­tions on com­puls­ory li­cens­ing of stand­ard es­sen­tial pat­ents (SEP)...
04/08/2014
CMS Em­ploy­ee In­vent­or Re­wards Sur­vey 2014
CMS, Europe’s largest leg­al ser­vices firm, has re­leased the res­ults of its second an­nu­al Em­ploy­ee In­vent­or Re­wards Sur­vey, an ana­lys­is of em­ploy­ee re­ward schemes and policies in Europe.The on­line sur­vey...
22 April 2020
CMS Ex­pert Guide to the Cov­id-19 pro­ced­ur­al dead­lines for IP law
An over­view by our In­tel­lec­tu­al Prop­erty Ex­perts As in all as­pects of busi­ness, COV­ID-19 is im­pact­ing the world of IP and the po­s­i­tion is con­stantly chan­ging. To help you pri­or­it­ise and plan, the Glob­al...
01 December 2020
EPO pri­or­ity claim en­ti­tle­ment – the “same ap­plic­ants” ap­proach up­held
In a Press Com­mu­niqué dated 6 Novem­ber 2020, the EPO sum­mar­ises the Tech­nic­al Board of Ap­peal 3.3.08 writ­ten de­cision re­cently is­sued in case T 844/18 con­firm­ing the re­voc­a­tion of a pat­ent re­lated to...
2014-01
Mod­i­fied dead­line for re­quest­ing fur­ther pro­cessing after the non-ob­serv­ance...
On Decem­ber 21st 2013 the Act amend­ing the In­dus­tri­al Prop­erty Act (ZIL-1D) came in­to force, amend­ing the op­tion to con­tin­ue the pro­cessing to ob­tain in­tel­lec­tu­al prop­erty rights after the non-ob­serv­ance...
24 November 2020
EU pav­ing the way to reg­u­late AI
Should AI be gran­ted IP rights? We are liv­ing in ex­traordin­ary times, times we might have dreamt of while watch­ing Star Trek. No tech­no­lo­gic­al ad­vance­ment has ever had an im­pact on every­day life to rival...
09 November 2020
CJEU rules that small sales of high-priced lux­ury sports cars and re­place­ment...
Back­ground Sev­er­al ques­tions were re­ferred fol­low­ing an ap­peal by the right­shold­er, Fer­rari, against the de­cision of the Ger­man court to or­der the re­voc­a­tion of two ‘TE­ST­AROSSA’ fig­ur­at­ive marks...
29 October 2020
EU Gen­er­al Court cla­ri­fies in­ter­pret­a­tion of “sat­is­fact­ory meth­od” in the...
In the re­cent case of Me­dac Gesell­schaft für klin­is­che Spezi­al­prä­par­ate mbH v European Com­mis­sion, the EU Gen­er­al Court has an­nulled a de­cision of the European Com­mis­sion in which it held that the ap­plic­ant’s...
28 October 2020
New EPO Guidelines ex­pec­ted re­gard­ing amend­ing a de­scrip­tion: what’s all...
Sum­mary The EPO re­quire­ment to amend the de­scrip­tion to con­form with al­lowed claims is chan­ging sig­ni­fic­antly. Ex­am­iners have already been giv­en in­tern­al guid­ance and re­vi­sions to the EPO Guidelines...
08 October 2020
Ger­many tries again to rat­i­fy Uni­fied Pat­ent Court-Agree­ment
A bill for ap­prov­al of the Agree­ment on the Uni­fied Pat­ent Court (UPCA), le­gis­la­tion that would al­low Ger­many to rat­i­fy this con­ven­tion and to par­ti­cip­ate in this in­ter­na­tion­al pat­ent court sys­tem, was...